RVTY(Revvity, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-01-02 | FY 截至 2023-01-01 | FY 截至 2023-12-31 | FY 截至 2024-12-29 | FY 截至 2025-12-28 |
|---|---|---|---|---|---|
| 营业收入 | $3.83B | $3.31B | $2.75B | $2.76B | $2.86B |
| 毛利润 | $2.43B | $1.99B | — | — | — |
| 营业利润 | $1.26B | $742.70M | $300.56M | $346.74M | $356.63M |
| 净利润 | $943.16M | $569.18M | $693.09M | $270.38M | $241.20M |
| 经营现金流 | $1.41B | $679.81M | $91.27M | $628.30M | $582.93M |
| 自由现金流 | $1.32B | $594.18M | $9.90M | $541.65M | $509.41M |
| 摊薄每股收益 | $8.08 | $4.50 | $5.55 | $2.20 | $2.07 |